Alpha-synuclein and its role in metal binding: Relevance to Parkinson's disease
- 15 February 2008
- journal article
- review article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 86 (3) , 496-503
- https://doi.org/10.1002/jnr.21461
Abstract
Parkinson's disease and some other neurodegenerative disorders are associated with a protein that can aggregate and form fibrils called alpha‐synuclein. Like many other proteins associated with neurodegenerative disorders, this protein has no known function, and the mechanism by which it could cause diseases is poorly defined. It was recently suggested that it binds copper. This review assesses what is known about alpha‐synuclein and its interaction with metals.Keywords
This publication has 102 references indexed in Scilit:
- The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategyBritish Journal of Pharmacology, 2005
- α-Synuclein Cooperates with CSPα in Preventing NeurodegenerationCell, 2005
- Iron, brain ageing and neurodegenerative disordersNature Reviews Neuroscience, 2004
- Neurodegenerative diseases and oxidative stressNature Reviews Drug Discovery, 2004
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- Conformational properties of α-synuclein in its free and lipid-associated states 1 1Edited by P. E. WrightJournal of Molecular Biology, 2001
- Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformationProceedings of the National Academy of Sciences, 2000
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively UnfoldedBiochemistry, 1996